XPOT and hepatocellular carcinoma: Likewise, XPOT mRNA levels increased 2.245-fold (Roessler liver dataset [24], P=8.41e-63) and 1.763-fold (Chen liver dataset [26], P=4.01e-14) but decreased −2.122-fold in HCC cancer tissues in another HCC dataset (Mas liver dataset [27], P=4.32e-07).